Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Angiari, S; O'Neill, LA.
Dimethyl fumarate: targeting glycolysis to treat MS.
Cell Res. 2018; 28(6): 613-615. Doi: 10.1038/s41422-018-0045-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz

Angiari Stefano

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Dimethyl fumarate (DMF) is an immunomodulatory drug used in patients with multiple sclerosis (MS) and psoriasis. Kornberg and colleagues shed new light on DMF activity, demonstrating that it blocks immune cell activation through inhibition of glycolysis via post-transcriptional modification of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), which confirms the pro-inflammatory role of glycolysis and points to potential new targets to treat inflammatory diseases such as MS.

Find related publications in this database (using NLM MeSH Indexing)

Administration, Oral -

Dimethyl Fumarate -

Glycolysis -

© Med Uni Graz • Impressum